Editors' picks of pharmaceutical science & technology innovations - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Editors' picks of pharmaceutical science & technology innovations
The latest in automation/IT/process control

Pharmaceutical Technology
Volume 37, Issue 7, pp. 18

Process modeling and manufacturing software features a Web-based user interface



The aspenONE software from Aspen Technology incorporates Aspen Plus, Aspen HYSYS, and any data historian into a Web interface that allows users to work with the software through Web-enabled devices. The interface gives users easy access to models and real-time plant information. The software can be used to compare model predictions and actual plant data and to conduct what-if scenarios for troubleshooting or optimizing. The software features a simple user interface and does not require specialized training. The software's search engine is designed for the process industries and enables users to find specific process information from across an enterprise in seconds.

Aspen Technology
http://www.aspentech.com/

Scientific innovation lifecycle management software manages large datasets



Accelrys Enterprise Platform 9.0 is an open, scientifically aware platform capable of managing "big data" and externalized research-collaboration networks. The platform offers enhancements in security, administration, and scientific services, which give organizations new tools for streamlining the lab-to-commercialization value chain and driving innovation in new product development. New capabilities allow for flexible administration and Internet deployments of clients outside of an organization's firewall with enhanced security, which enables secure and efficient interaction with external partners. The platform also offers broad scientific collections that are capable of handling structured and unstructured data, biological sequences, chemical structures, images, and text. The platform's reporting capabilities enable end-users to interpret and interact with data to drive more informed decision-making.

Accelrys
http://www.accelrys.com/


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here